awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38582650-C14AAD63-A568-4507-B6A2-7B0C338BA8C3
Q38582650-C14AAD63-A568-4507-B6A2-7B0C338BA8C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38582650-C14AAD63-A568-4507-B6A2-7B0C338BA8C3
Bortezomib in the treatment of mantle cell lymphoma.
P2860
Q38582650-C14AAD63-A568-4507-B6A2-7B0C338BA8C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38582650-C14AAD63-A568-4507-B6A2-7B0C338BA8C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f80d34a413c51a3276a2583793f3981676c663b
P2860
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.